FDA Changes Enforcement Policy for Homeopathic Drugs
Today, the Food and Drug Administration (“FDA”) announced it is withdrawing the Compliance Policy Guide (“CPG”) entitled, “Conditions Under Which Homeopathic Drugs May be Marketed,” which was issued in 1988 and describes the agency’s enforcement policy for such products. The withdrawal is applicable today. The FDA is implementing a risk-based enforcement policy in its place. […]
